Nadine Paiement

Title: Innovations by Nadine Paiement: Pioneering Oral Film Formulations

Introduction

Nadine Paiement is an accomplished inventor based in St-Laurent, Canada. With a remarkable portfolio of 19 patents, she has made significant contributions to the field of pharmaceutical formulations, particularly in the development of novel oral films.

Latest Patents

Among her latest inventions is the "Lipophilic Active Oral Film Formulation and Method of Making the Same." This innovative patent describes a method for formulating oral films that include lipophilic active ingredients, specifically those with a positive log P. The technique involves dispersing lipophilic actives in a carrier oil and creating emulsified oil droplets within a polymer matrix. This method results in oral films that maintain a stable emulsion with up to 40% oil phase, significantly enhancing the amount of lipophilic actives in the formulation while preserving the film's characteristics. Additionally, her patent for an "Oral Film Formulation for Modulating Absorption Profile" introduces a dosage form employing high-viscosity polymer to effectively control the absorption profile of active agents, thereby improving dosage efficiency and administration convenience.

Career Highlights

Nadine is currently associated with Intelgenx Corporation, where she utilizes her expertise in pharmaceutical science to drive innovation forward. Her work has laid the foundation for new pathways in drug formulation and delivery systems, enhancing the capabilities and applications of oral dosage forms.

Collaborations

Throughout her career, Nadine has collaborated with notable professionals such as Rodolphe Obeid and Horst G Zerbe. Their joint efforts have fostered a productive environment, leading to the advancement of technologies aimed at improving patient outcomes through effective drug delivery.

Conclusion

Nadine Paiement's inventive contributions and patents significantly impact the pharmaceutical industry, especially in oral film formulations. With her ongoing research and development efforts at Intelgenx Corporation, she continues to pave the way for innovative solutions that address complex challenges in drug delivery. Her dedication exemplifies the spirit of innovation essential for advancing modern medicine.